“Colpire nel segno” was the first consumer campaign by Neopharmed Gentili to promote and build awareness around Xioglican and its two formulations: Xioglican Crema® and Xioglican Gel®.
The Xioglican range of products are medical devices intended for topical use made up of glycosaminoglycan polysulphate, hyaluronic acid and other compounds with high moisturizing and soothing properties, all of which aid skin restoration and healing, even in cases where it is altered by peripheral circulatory disorders or by edemas and hematomas.
The media campaign ran from July to September 2021, and was carried out by means of advertising campaigns on major social media platforms, including Facebook, Instagram (using the Stories format), and Google Search.
The www.xioglican.it website was also created, containing additional information regarding the two products and the issues they address, as a way of becoming a reference point for consumers looking online for a solution to bothersome edemas and hematomas or circulatory disorders that can affect the wellbeing of the legs.
We therefore began developing our digital Brand Identity for users who use these digital channels as a way of informing themselves and seeking solutions to their problems.